Researchers at the University of Modena and Reggio Emilia in Italy have recently developed a method for treating patients with the genetic skin disease Epidermolyisis Bullosa (EB). The process is an example of translational genomics, in which the researchers extract autologous (the patient’s own) stem cells, correct the defective gene that caused the EB, and then transplant the cells back into the patient.
In addition to being quite painful, EB causes blisters and fragile skin, which can lead to life-threatening infections. Utilizing the patient’s own stem cells prevents these symptoms by treating the source of the disease, i.e. the defective gene, without running the risk of the immune system rejecting donated cells.
The research is an example of how scientists are utilizing the patient’s own stem cells to create more effective regenerative treatments leading to better outcomes. To learn more about the value of preserving your own stem cells for use in future regenerative therapies, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full abstract, click here.
The Future of Regenerative Medicine is Now™.